Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood

M. J. Maxwell, S. A. Messer, R. J. Hollis, L. Boyken, S. Tendolkar, D. J. Diekema, M. A. Pfaller, L. Steele-Moore, G. Denys, C. Staley, J. R. Dipersio, M. Saubolle, M. L. Wilson, G. D. Overturf, L. R. Peterson, P. C. Schreckenberger, G. V. Doern

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The performance of Etest in fluconazole and voriconazole testing of 279 isolates of uncommon Candida spp. was assessed in comparison with the National Committee for Clinical Laboratory Standards (NCCLS)-approved standard broth microdilution (BMD) method. The NCCLS method employed RPMI 1640 broth medium, and MICs were read after incubation for 48 h at 35°C. Etest MICs were determined with RPMI agar containing 2% glucose and were read after incubation for 48 h at 35°C. The isolates include Candida krusei, C. lusitaniae, C. guilliermondii, C. kefyr, C. rugosa, C. lipolytica, C. pelliculosa, C. dubliniensis, C. famata, C. zeylanoides, C. inconspicua, and C. norvegensis. Overall agreement between Etest and BMD MICs was 96% for fluconazole and 95% for voriconazole. Where a discrepancy was observed between Etest and the reference method, the Etest tended to give lower values with both fluconazole and voriconazole. The Etest method using RPMI agar appears to be a useful method for determining fluconazole and voriconazole susceptibilities of uncommon species of Candida.

Original languageEnglish (US)
Pages (from-to)1087-1090
Number of pages4
JournalJournal of clinical microbiology
Volume41
Issue number3
DOIs
StatePublished - Mar 1 2003

Fingerprint

Disk Diffusion Antimicrobial Tests
Fluconazole
Candida
Agar
Voriconazole
Glucose

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood. / Maxwell, M. J.; Messer, S. A.; Hollis, R. J.; Boyken, L.; Tendolkar, S.; Diekema, D. J.; Pfaller, M. A.; Steele-Moore, L.; Denys, G.; Staley, C.; Dipersio, J. R.; Saubolle, M.; Wilson, M. L.; Overturf, G. D.; Peterson, L. R.; Schreckenberger, P. C.; Doern, G. V.

In: Journal of clinical microbiology, Vol. 41, No. 3, 01.03.2003, p. 1087-1090.

Research output: Contribution to journalArticle

Maxwell, MJ, Messer, SA, Hollis, RJ, Boyken, L, Tendolkar, S, Diekema, DJ, Pfaller, MA, Steele-Moore, L, Denys, G, Staley, C, Dipersio, JR, Saubolle, M, Wilson, ML, Overturf, GD, Peterson, LR, Schreckenberger, PC & Doern, GV 2003, 'Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood', Journal of clinical microbiology, vol. 41, no. 3, pp. 1087-1090. https://doi.org/10.1128/JCM.41.3.1087-1090.2003
Maxwell, M. J. ; Messer, S. A. ; Hollis, R. J. ; Boyken, L. ; Tendolkar, S. ; Diekema, D. J. ; Pfaller, M. A. ; Steele-Moore, L. ; Denys, G. ; Staley, C. ; Dipersio, J. R. ; Saubolle, M. ; Wilson, M. L. ; Overturf, G. D. ; Peterson, L. R. ; Schreckenberger, P. C. ; Doern, G. V. / Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood. In: Journal of clinical microbiology. 2003 ; Vol. 41, No. 3. pp. 1087-1090.
@article{cf908579d1004af789158b814f979d5d,
title = "Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood",
abstract = "The performance of Etest in fluconazole and voriconazole testing of 279 isolates of uncommon Candida spp. was assessed in comparison with the National Committee for Clinical Laboratory Standards (NCCLS)-approved standard broth microdilution (BMD) method. The NCCLS method employed RPMI 1640 broth medium, and MICs were read after incubation for 48 h at 35°C. Etest MICs were determined with RPMI agar containing 2{\%} glucose and were read after incubation for 48 h at 35°C. The isolates include Candida krusei, C. lusitaniae, C. guilliermondii, C. kefyr, C. rugosa, C. lipolytica, C. pelliculosa, C. dubliniensis, C. famata, C. zeylanoides, C. inconspicua, and C. norvegensis. Overall agreement between Etest and BMD MICs was 96{\%} for fluconazole and 95{\%} for voriconazole. Where a discrepancy was observed between Etest and the reference method, the Etest tended to give lower values with both fluconazole and voriconazole. The Etest method using RPMI agar appears to be a useful method for determining fluconazole and voriconazole susceptibilities of uncommon species of Candida.",
author = "Maxwell, {M. J.} and Messer, {S. A.} and Hollis, {R. J.} and L. Boyken and S. Tendolkar and Diekema, {D. J.} and Pfaller, {M. A.} and L. Steele-Moore and G. Denys and C. Staley and Dipersio, {J. R.} and M. Saubolle and Wilson, {M. L.} and Overturf, {G. D.} and Peterson, {L. R.} and Schreckenberger, {P. C.} and Doern, {G. V.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1128/JCM.41.3.1087-1090.2003",
language = "English (US)",
volume = "41",
pages = "1087--1090",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood

AU - Maxwell, M. J.

AU - Messer, S. A.

AU - Hollis, R. J.

AU - Boyken, L.

AU - Tendolkar, S.

AU - Diekema, D. J.

AU - Pfaller, M. A.

AU - Steele-Moore, L.

AU - Denys, G.

AU - Staley, C.

AU - Dipersio, J. R.

AU - Saubolle, M.

AU - Wilson, M. L.

AU - Overturf, G. D.

AU - Peterson, L. R.

AU - Schreckenberger, P. C.

AU - Doern, G. V.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - The performance of Etest in fluconazole and voriconazole testing of 279 isolates of uncommon Candida spp. was assessed in comparison with the National Committee for Clinical Laboratory Standards (NCCLS)-approved standard broth microdilution (BMD) method. The NCCLS method employed RPMI 1640 broth medium, and MICs were read after incubation for 48 h at 35°C. Etest MICs were determined with RPMI agar containing 2% glucose and were read after incubation for 48 h at 35°C. The isolates include Candida krusei, C. lusitaniae, C. guilliermondii, C. kefyr, C. rugosa, C. lipolytica, C. pelliculosa, C. dubliniensis, C. famata, C. zeylanoides, C. inconspicua, and C. norvegensis. Overall agreement between Etest and BMD MICs was 96% for fluconazole and 95% for voriconazole. Where a discrepancy was observed between Etest and the reference method, the Etest tended to give lower values with both fluconazole and voriconazole. The Etest method using RPMI agar appears to be a useful method for determining fluconazole and voriconazole susceptibilities of uncommon species of Candida.

AB - The performance of Etest in fluconazole and voriconazole testing of 279 isolates of uncommon Candida spp. was assessed in comparison with the National Committee for Clinical Laboratory Standards (NCCLS)-approved standard broth microdilution (BMD) method. The NCCLS method employed RPMI 1640 broth medium, and MICs were read after incubation for 48 h at 35°C. Etest MICs were determined with RPMI agar containing 2% glucose and were read after incubation for 48 h at 35°C. The isolates include Candida krusei, C. lusitaniae, C. guilliermondii, C. kefyr, C. rugosa, C. lipolytica, C. pelliculosa, C. dubliniensis, C. famata, C. zeylanoides, C. inconspicua, and C. norvegensis. Overall agreement between Etest and BMD MICs was 96% for fluconazole and 95% for voriconazole. Where a discrepancy was observed between Etest and the reference method, the Etest tended to give lower values with both fluconazole and voriconazole. The Etest method using RPMI agar appears to be a useful method for determining fluconazole and voriconazole susceptibilities of uncommon species of Candida.

UR - http://www.scopus.com/inward/record.url?scp=0037337105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037337105&partnerID=8YFLogxK

U2 - 10.1128/JCM.41.3.1087-1090.2003

DO - 10.1128/JCM.41.3.1087-1090.2003

M3 - Article

C2 - 12624034

AN - SCOPUS:0037337105

VL - 41

SP - 1087

EP - 1090

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 3

ER -